Attachment L-9.8 PA_ST_QL List.XLSX
XLSX spreadsheet 2 MB Posted
- Attached to
- DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) Federal contract opportunity
- Solicitation number
- HT940220R0002
- Issued by
- Defense Health Agency
About this file
This draft request for proposals from the Defense Health Agency concerns pharmacy services under the TRICARE program for the fifth generation of the TRICARE Pharmacy contract, known as TPharm5. The potential contract would have an 18-month transition period and seven 1-year option periods for healthcare delivery, with a potential total period of performance of 9 years. The draft RFP includes sections on the contract structure, specialty pharmacy services, retail pharmacy networks, compounded medications, care coordination, patient safety notifications, and quality control. Comments from industry on the draft RFP are requested by 17 January 2020 to help the agency refine its approach for providing high quality pharmacy services within statutory and regulatory requirements. An information session on the draft RFP will be held on 11 December 2019.
View the file
Other files for this federal contract opportunity
Show all 50
DRAFT RFP TRICARE Pharmacy Services, 5th Generation (TPharm5) has more files on GovTribe.
On GovTribe
Work with this file on GovTribe
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Manual PA FDB GCN NDC11 TRADE NAME STRENGTH DESC GCDF DESC ROUTE DESC FORMULARY STATUS F=LEGEND
I=INSULIN
| O=OTC | SUBCODE | PACK SIZE | MANUFACTURER NAME | Rule Name | ||||||||
| 00575 | 00002814801 | HUMATROPE | 12 MG | CARTRIDGE (EA) | INJECTION | N | F | Brand | 1 | ELI LILLY & CO. | PA DRUGS, DOD PA REQUIRED | |
| 05679 | 66733077301 | INSULIN LISPRO | 100/ML | VIAL (ML) | SUBCUTANEOUS | Y | I | Brand | 10 | ELI LILLY & CO. | TPA - INSULIN LISPRO, INSULIN LISPRO KWIKPEN U-100 REQUIRES PRIOR AUTHORIZATION | |
| 07055 | 00456140511 | BYSTOLIC | 5 MG | TABLET | ORAL | N | F | Brand | 1 | FOREST/ALLERGAN | PA DRUGS, DOD PA REQUIRED | |
| 07055 | 00456140530 | BYSTOLIC | 5 MG | TABLET | ORAL | N | F | Brand | 30 | FOREST/ALLERGAN | PA DRUGS, DOD PA REQUIRED | |
| 07055 | 00456140563 | BYSTOLIC | 5 MG | TABLET | ORAL | N | F | Brand | 100 | FOREST/ALLERGAN | PA DRUGS, DOD PA REQUIRED | |
| 07055 | 00456140590 | BYSTOLIC | 5 MG | TABLET | ORAL | N | F | Brand | 90 | FOREST/ALLERGAN | PA DRUGS, DOD PA REQUIRED | |
| 10495 | 42227008105 | CINRYZE | 500 (5 ML) | VIAL (EA) | INTRAVENOUS | Y | F | Brand | 1 | VIROPHARMA/SHIR | PA DRUGS, DOD PA REQUIRED | |
| 10554 | 00013264681 | GENOTROPIN | 12 MG/ML | CARTRIDGE (EA) | SUBCUTANEOUS | N | F | Brand | 1 | PHARMACI/PFIZER | PA DRUGS, DOD PA REQUIRED | |
| 10561 | 54396011111 | OXANDRIN | 2.5 MG | TABLET | ORAL | N | F | Multi-Source Brand | 100 | SAVIENT PHARMAC | NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED | |
| 11162 | 58607010565 | MYNATAL-Z | 65 MG-1 MG | TABLET | ORAL | N | F | Generic | 100 | ME PHARM | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 11162 | 58607081120 | MYNATAL PLUS | 65 MG-1 MG | TABLET | ORAL | N | F | Generic | 100 | ME PHARM | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 11168 | 58607010359 | MYNATAL | 65 MG-1 MG | CAPSULE | ORAL | N | F | Generic | 100 | ME PHARM | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 11178 | 58607010390 | MYNATE 90 PLUS | 90-50-1MG | TABLET, EXTENDED RELEASE | ORAL | N | F | Generic | 100 | ME PHARM | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 12763 | 42546081230 | PR NATAL 430 | 29-1-430MG | COMBINATION PACKAGE (EA) | ORAL | N | F | Generic | 60 | PRUGEN PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 12767 | 44087108801 | SAIZEN | 8.8 MG | VIAL (EA) | SUBCUTANEOUS | N | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 12767 | 44087338807 | ZORBTIVE | 8.8 MG | VIAL (EA) | SUBCUTANEOUS | N | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 12921 | 00052031301 | FOLLISTIM AQ | 300/0.36ML | CARTRIDGE (ML) | SUBCUTANEOUS | Y | F | Brand | 0.42 | ORGANON PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 12922 | 00052031601 | FOLLISTIM AQ | 600/0.72ML | CARTRIDGE (ML) | SUBCUTANEOUS | Y | F | Brand | 0.78 | ORGANON PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 14158 | 23359010530 | C-NATE DHA | 28-1-200MG | CAPSULE | ORAL | N | F | Generic | 30 | CENTURION LABS | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14158 | 35573020030 | RELNATE DHA | 28-1-200MG | CAPSULE | ORAL | N | F | Generic | 30 | BUREL PHARMACEU | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14158 | 69543037030 | VIRT-NATE DHA | 28-1-200MG | CAPSULE | ORAL | N | F | Generic | 30 | VIRTUS PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14315 | 13811005030 | ULTIMATECARE ONE NF | 27-1-50 MG | CAPSULE | ORAL | N | F | Generic | 30 | TRIGEN LABORATO | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14404 | 00002840001 | FORTEO | 20MCG/DOSE | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 2.4 | ELI LILLY & CO. | PA DRUGS, DOD PA REQUIRED | |
| 14405 | 13811004930 | ULTIMATECARE ONE | 27-1-330MG | CAPSULE | ORAL | N | F | Generic | 30 | TRIGEN LABORATO | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14485 | 42546051830 | PR NATAL 430 EC | 29-1-430MG | COMBINATION PACKAGE, TABLET AND DR CAP | ORAL | N | F | Generic | 60 | PRUGEN PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14711 | 11026262903 | OBSTETRIX DHA | 29-1-50 MG | COMBINATION PACKAGE, TABLET AND DR CAP | ORAL | N | F | Generic | 60 | SEYER INC. | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14711 | 67555014830 | OBTREX DHA | 29-1-50 MG | COMBINATION PACKAGE, TABLET AND DR CAP | ORAL | N | F | Brand | 60 | PRONOVA CORP | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14711 | 98826011069 | OBSTETRIX DHA | 29-1-50 MG | COMBINATION PACKAGE, TABLET AND DR CAP | ORAL | N | F | Generic | 60 | SEYER INC. | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 14978 | 00054052121 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | WEST-WARD/HIKMA | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 00591251260 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | ACTAVIS/TEVA | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 10148012560 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | COTHERIX, INC. | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 47335003986 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | SUN PHARMA GLOB | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 49884005902 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | PAR PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 65162087406 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | AMNEAL PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 66215010203 | TRACLEER | 125 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 30 | ACTELION PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 66215010206 | TRACLEER | 125 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 60 | ACTELION PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 14978 | 68382044714 | BOSENTAN | 125 MG | TABLET | ORAL | Y | F | Generic | 60 | ZYDUS PHARMACEU | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 00054052021 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | WEST-WARD/HIKMA | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 00591251160 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | ACTAVIS/TEVA | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 10148062560 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | COTHERIX, INC. | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 47335003886 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | SUN PHARMA GLOB | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 49884005802 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | PAR PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 65162087306 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | AMNEAL PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 66215010103 | TRACLEER | 62.5 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 30 | ACTELION PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 66215010106 | TRACLEER | 62.5 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 60 | ACTELION PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 14979 | 68382044614 | BOSENTAN | 62.5 MG | TABLET | ORAL | Y | F | Generic | 60 | ZYDUS PHARMACEU | PA DRUGS, DOD PA REQUIRED | |
| 15381 | 27505009060 | ZELNORM | 6 MG | TABLET | ORAL | N | F | Brand | 60 | US WORLDMEDS/AL | PA DRUGS, DOD PA REQUIRED | |
| 15596 | 46287002001 | CAROSPIR | 25 MG/5 ML | SUSPENSION, ORAL (FINAL DOSE FORM) | ORAL | N | F | Brand | 473 | CMP PHARMA, INC | TPA - CAROSPIR ORAL SUSPENSION FOR PTS >12 YEARS OF AGE REQUIRES PRIOR AUTHORIZATION | |
| 15596 | 46287002004 | CAROSPIR | 25 MG/5 ML | SUSPENSION, ORAL (FINAL DOSE FORM) | ORAL | N | F | Brand | 118 | CMP PHARMA, INC | TPA - CAROSPIR ORAL SUSPENSION FOR PTS >12 YEARS OF AGE REQUIRES PRIOR AUTHORIZATION | |
| 15751 | 42546014516 | BENZOYL PEROXIDE | 7 % | CLEANSER (ML) | TOPICAL | Y | F | Generic | 473 | PRUGEN PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 15751 | 43538011016 | PACNEX | 7 % | CLEANSER (ML) | TOPICAL | Y | F | Multi-Source Brand | 480 | MEDIMETRIKS PHA | PA DRUGS, DOD PA REQUIRED | |
| 15985 | 13811054330 | TARON PRENATAL | 30-1.2-55 | CAPSULE | ORAL | N | F | Generic | 30 | TRIGEN LABORATO | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 16134 | 52427027430 | NAPRELAN | 750 MG | TABLET,EXTENDED RELEASE MULTIPHASE 24 HR | ORAL | N | F | Brand | 30 | ALMATICA PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 16153 | 42192032030 | PNV-SELECT | 27 MG-1 MG | TABLET | ORAL | N | F | Generic | 30 | ACELLA PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 16153 | 42192032090 | PNV-SELECT | 27 MG-1 MG | TABLET | ORAL | N | F | Generic | 90 | ACELLA PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 16153 | 69543024190 | VIRT-PN | 27 MG-1 MG | TABLET | ORAL | N | F | Generic | 90 | VIRTUS PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 16168 | 42546001718 | BENZEPRO | 7 % | CLEANSER (GRAM) | TOPICAL | Y | F | Multi-Source Brand | 180 | PRUGEN PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 16168 | 42546014518 | PR BENZOYL PEROXIDE | 7 % | CLEANSER (GRAM) | TOPICAL | Y | F | Multi-Source Brand | 180 | PRUGEN PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 16192 | 00682005110 | CROTAN | 10 % | LOTION (GRAM) | TOPICAL | Y | F | Generic | 227 | MARNEL PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 16192 | 00682005120 | CROTAN | 10 % | LOTION (GRAM) | TOPICAL | Y | F | Generic | 60 | MARNEL PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 16192 | 00682005130 | CROTAN | 10 % | LOTION (GRAM) | TOPICAL | Y | F | Generic | 454 | MARNEL PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 16192 | 10631009216 | EURAX | 10 % | LOTION (GRAM) | TOPICAL | Y | F | Brand | 454 | RANBAXY/SUN PHA | PA DRUGS, DOD PA REQUIRED | |
| 16192 | 10631009260 | EURAX | 10 % | LOTION (GRAM) | TOPICAL | Y | F | Brand | 60 | RANBAXY/SUN PHA | PA DRUGS, DOD PA REQUIRED | |
| 16498 | 11086003201 | VANOXIDE-HC | 5 %-0.5 % | SUSPENSION, TOPICAL (GRAM) | TOPICAL | Y | F | Brand | 25 | SUMMERS LABS/MA | PA DRUGS, DOD PA REQUIRED | |
| 16766 | 55495011101 | ATABEX EC | 29-1-50 MG | TABLET, ENTERIC COATED | ORAL | N | F | Brand | 100 | ADVANCED MED | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 16938 | 68712002301 | INOVA | 8%-5% | COMBINATION PACKAGE (EA) | TOPICAL | Y | F | Brand | 58 | INNOCUTIS/EPI H | PA DRUGS, DOD PA REQUIRED | |
| 16939 | 68712001301 | INOVA | 4 %-5 % | COMBINATION PACKAGE (EA) | TOPICAL | Y | F | Brand | 58 | INNOCUTIS/EPI H | PA DRUGS, DOD PA REQUIRED | |
| 16996 | 00187581130 | APLENZIN | 348MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Brand | 30 | VALEANT/BAUSCH | PA DRUGS, DOD PA REQUIRED | |
| 17050 | 00187581230 | APLENZIN | 522MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Brand | 30 | VALEANT/BAUSCH | PA DRUGS, DOD PA REQUIRED | |
| 17332 | 42192012560 | BPO | 6 % | TOWELETTE (EA) | TOPICAL | Y | F | Generic | 60 | ACELLA PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 17332 | 42546001660 | BENZEPRO | 6 % | TOWELETTE (EA) | TOPICAL | Y | F | Generic | 60 | PRUGEN PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 17475 | 50242004314 | NUTROPIN AQ | 10 MG/2 ML | CARTRIDGE (ML) | SUBCUTANEOUS | N | F | Brand | 2 | GENENTECH, INC. | PA DRUGS, DOD PA REQUIRED | |
| 17900 | 46672086046 | CHLORZOXAZONE | 250 MG | TABLET | ORAL | Y | F | Generic | 60 | MIKART, INC | PA DRUGS, DOD PA REQUIRED | |
| 17900 | 69499033060 | CHLORZOXAZONE | 250 MG | TABLET | ORAL | Y | F | Generic | 60 | SOLUBIOMIX, LLC | PA DRUGS, DOD PA REQUIRED | |
| 17900 | 69597033060 | CHLORZOXAZONE | 250 MG | TABLET | ORAL | Y | F | Generic | 60 | BASIEM | PA DRUGS, DOD PA REQUIRED | |
| 17988 | 58487000101 | DURLAZA | 162.5 MG | CAPSULE, EXT RELEASE 24 HR | ORAL | N | F | Brand | 30 | NEW HAVEN PHARM | NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED | |
| 18104 | 68727010001 | XYREM | 500 MG/ML | SOLUTION, ORAL | ORAL | Y | F | Brand | 180 | JAZZ PHARMACEUT | XYREM (DG=MSL6277), DOD PA REQUIRED | |
| 18160 | 00067434504 | TRANSDERM-SCOP | 1 MG/3 DAY | PATCH,TRANSDERMAL 3 DAY | TRANSDERMAL | N | F | Multi-Source Brand | 4 | NOVARTIS CONSUM | NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED | |
| 18160 | 00067434604 | TRANSDERM-SCOP | 1 MG/3 DAY | PATCH,TRANSDERMAL 3 DAY | TRANSDERMAL | Y | F | Multi-Source Brand | 4 | GSK CONSUMER HE | NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED | |
| 18265 | 54396011060 | OXANDRIN | 10 MG | TABLET | ORAL | N | F | Multi-Source Brand | 60 | SAVIENT PHARMAC | NON-FCP MSL6274 RTL/MDP <> COB PA REQUIRED | |
| 18703 | 00456142030 | BYSTOLIC | 20 MG | TABLET | ORAL | N | F | Brand | 30 | FOREST/ALLERGAN | PA DRUGS, DOD PA REQUIRED | |
| 18703 | 00456142090 | BYSTOLIC | 20 MG | TABLET | ORAL | N | F | Brand | 90 | FOREST/ALLERGAN | PA DRUGS, DOD PA REQUIRED | |
| 18924 | 00074379902 | HUMIRA | 40MG/0.8ML | SYRINGE KIT (EA) | SUBCUTANEOUS | Y | F | Brand | 2 | ABBVIE US LLC | PA DRUGS, DOD PA REQUIRED | |
| 18924 | 00074379903 | HUMIRA PEDIATRIC | 40MG/0.8ML | SYRINGE KIT (EA) | SUBCUTANEOUS | Y | F | Brand | 3 | ABBVIE US LLC | PA DRUGS, DOD PA REQUIRED | |
| 18924 | 00074379906 | HUMIRA PEDIATRIC | 40MG/0.8ML | SYRINGE KIT (EA) | SUBCUTANEOUS | Y | F | Brand | 6 | ABBVIE US LLC | PA DRUGS, DOD PA REQUIRED | |
| 18995 | 00002446330 | CIALIS | 10 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | ELI LILLY & CO. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 00093301856 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 00378697293 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | MYLAN | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 13668056730 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | TORRENT PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 27241011303 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | AJANTA PHARMA L | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 29300028813 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | UNICHEM PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 31722064530 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | CAMBER PHARMACE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 35573041130 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | BUREL PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 43598057430 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | DR. REDDY'S LAB | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 47335001183 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | SUN PHARMA GLOB | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 60505468503 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | APOTEX CORP | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 62332017930 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | ALEMBIC PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 66993070230 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | PRASCO LABS | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 68180092106 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | LUPIN PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 68382089806 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 69097037502 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | CIPLA USA, INC. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 69097037505 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 90 | CIPLA USA, INC. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18995 | 69238134803 | TADALAFIL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | AMNEAL PHARMACE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 00002446430 | CIALIS | 20 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | ELI LILLY & CO. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 00093301956 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 00378697393 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | MYLAN | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 13668056830 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | TORRENT PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 16729037210 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | ACCORD HEALTHCA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 27241011403 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | AJANTA PHARMA L | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 29300028913 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | UNICHEM PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 31722064630 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | CAMBER PHARMACE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 35573041230 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | BUREL PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 43598057330 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | DR. REDDY'S LAB | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 47335001283 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | SUN PHARMA GLOB | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 60505468603 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | APOTEX CORP | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 62332018030 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | ALEMBIC PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 66993070330 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | PRASCO LABS | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 68180092206 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | LUPIN PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 68382089906 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 69097037602 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | CIPLA USA, INC. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 69097037605 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 90 | CIPLA USA, INC. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 18996 | 69238134903 | TADALAFIL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | AMNEAL PHARMACE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19216 | 00023916330 | RESTASIS | 0.05 % | DROPPERETTE, SINGLE-USE DROP DISPENSER | OPHTHALMIC (EYE) | Y | F | Brand | 30 | ALLERGAN INC. | TPA - OPHTHALMIC RESTASIS/MULTIDOSE,CEQUA,XIIDRA W/O USE IN LAST 120 DAYS REQUIRES PRIOR AUTH | |
| 19216 | 00023916360 | RESTASIS | 0.05 % | DROPPERETTE, SINGLE-USE DROP DISPENSER | OPHTHALMIC (EYE) | Y | F | Brand | 60 | ALLERGAN INC. | TPA - OPHTHALMIC RESTASIS/MULTIDOSE,CEQUA,XIIDRA W/O USE IN LAST 120 DAYS REQUIRES PRIOR AUTH | |
| 19326 | 00093765356 | VARDENAFIL HCL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19326 | 00173082913 | LEVITRA | 5 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | GLAXOSMITHKLINE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19326 | 00527280132 | VARDENAFIL HCL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | LANNETT CO. INC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19326 | 70710106903 | VARDENAFIL HCL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19327 | 00093765456 | VARDENAFIL HCL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19327 | 00173083013 | LEVITRA | 10 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | GLAXOSMITHKLINE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19327 | 00527280232 | VARDENAFIL HCL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | LANNETT CO. INC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19327 | 70710107003 | VARDENAFIL HCL | 10 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19328 | 00093765556 | VARDENAFIL HCL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19328 | 00173083113 | LEVITRA | 20 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | GLAXOSMITHKLINE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19328 | 00527280332 | VARDENAFIL HCL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | LANNETT CO. INC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19328 | 70710107103 | VARDENAFIL HCL | 20 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 19523 | 58809035930 | VANATOL S | 50-325/15 | SOLUTION, ORAL | ORAL | Y | F | Brand | 30 | G.M. PHARM | PA DRUGS, DOD PA REQUIRED | |
| 19523 | 58809082016 | VANATOL LQ | 50-325/15 | SOLUTION, ORAL | ORAL | Y | F | Brand | 473 | G.M. PHARM | PA DRUGS, DOD PA REQUIRED | |
| 19948 | 52244003060 | STRIANT | 30 MG | MUCOADHESIVE SYSTEM,EXTEND.RELEASE 12 HR | BUCCAL | Y | F | Brand | 60 | AUXILIUM/ENDO P | PA DRUGS, DOD PA REQUIRED | |
| 19980 | 66992039910 | REGIMEX | 25 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 100 | WRASER PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19980 | 75834010001 | BENZPHETAMINE HCL | 25 MG | TABLET | ORAL | Y | F | Generic | 100 | NIVAGEN PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 10702004001 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 10702004003 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 30 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 10702004050 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 500 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 23155017401 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 100 | HERITAGE PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 23155017403 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 30 | HERITAGE PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 42806008101 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 100 | EPIC PHARMA LLC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 42806008130 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 30 | EPIC PHARMA LLC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 75834010201 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 100 | NIVAGEN PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 75834010205 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 500 | NIVAGEN PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 19981 | 75834010230 | BENZPHETAMINE HCL | 50 MG | TABLET | ORAL | Y | F | Generic | 30 | NIVAGEN PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20258 | 00093765256 | VARDENAFIL HCL | 2.5 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20258 | 00173082813 | LEVITRA | 2.5 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | GLAXOSMITHKLINE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20258 | 00527280032 | VARDENAFIL HCL | 2.5 MG | TABLET | ORAL | N | F | Generic | 30 | LANNETT CO. INC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20258 | 70710106803 | VARDENAFIL HCL | 2.5 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20383 | 10631011731 | ABSORICA | 30 MG | CAPSULE | ORAL | N | F | Brand | 30 | RANBAXY/SUN PHA | PA DRUGS, DOD PA REQUIRED | |
| 20383 | 10631011769 | ABSORICA | 30 MG | CAPSULE | ORAL | N | F | Brand | 10 | RANBAXY/SUN PHA | PA DRUGS, DOD PA REQUIRED | |
| 20589 | 44087907001 | GONAL-F | 1050 UNIT | VIAL (EA) | SUBCUTANEOUS | Y | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 20590 | 44087903001 | GONAL-F | 450 UNIT | VIAL (EA) | SUBCUTANEOUS | Y | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 20593 | 44087900501 | GONAL-F RFF | 75 UNIT | VIAL (EA) | SUBCUTANEOUS | Y | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 20593 | 44087900506 | GONAL-F RFF | 75 UNIT | VIAL (EA) | SUBCUTANEOUS | Y | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 20691 | 00093211001 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | TEVA USA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 00185064401 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 00185064410 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 00527174201 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 00527174210 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 10702002601 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 10702002610 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 11534015701 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 11534015703 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 13107010501 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | AUROBINDO PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 51224020350 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | TAGI PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 51224020370 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | TAGI PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 69315020201 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20691 | 69315020210 | PHENTERMINE HCL | 15 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00093210901 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | TEVA USA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00185064701 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00185064710 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00185500001 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00185500010 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527059701 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527059710 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527130801 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527130810 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527131001 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527131010 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527143801 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 00527143810 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 10702002701 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 10702002710 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 10702002801 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 10702002810 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 11534017601 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 11534017603 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 13107010601 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | AUROBINDO PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 51224020250 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | TAGI PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 51224020270 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | TAGI PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 53489043301 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | MUTUAL PHARM CO | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 53489043310 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | MUTUAL PHARM CO | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 69315020301 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20692 | 69315020310 | PHENTERMINE HCL | 30 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 00527174301 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 00527174310 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 00527174330 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 30 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 10702002901 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 10702002910 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 11534015901 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 100 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 11534015903 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 11534015930 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 30 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 42806052401 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 100 | EPIC PHARMA LLC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 57844001901 | ADIPEX-P | 37.5 MG | CAPSULE | ORAL | Y | F | Multi-Source Brand | 100 | TEVA SELECT BRA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 69315020401 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 100 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 69315020403 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 30 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20693 | 69315020410 | PHENTERMINE HCL | 37.5 MG | CAPSULE | ORAL | Y | F | Generic | 1000 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 00527144501 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 00527144510 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 00603519216 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 30 | QUALITEST/PAR P | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 00603519221 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | QUALITEST/PAR P | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 00603519232 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | QUALITEST/PAR P | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 10702002501 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 10702002503 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 30 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 10702002510 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 11534016001 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 11534016003 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 11534016030 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 30 | SUNRISE PHARMAC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 13107006101 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | AUROBINDO PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 13107006199 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | AUROBINDO PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 43547040410 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | SOLCO HEALTHCAR | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 43547040411 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | SOLCO HEALTHCAR | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 51224010150 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | TAGI PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 51224010170 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | TAGI PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 53489067601 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | MUTUAL PHARM CO | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 53489067610 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | MUTUAL PHARM CO | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 57844000901 | ADIPEX-P | 37.5 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 100 | TEVA SELECT BRA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 57844000956 | ADIPEX-P | 37.5 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 30 | TEVA SELECT BRA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 64980019001 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | RISING PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 64980019003 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 30 | RISING PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 64980019010 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | RISING PHARM | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 68645048554 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 30 | LEGACY PHARMACE | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 69315020101 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 100 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 69315020103 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 30 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20713 | 69315020110 | PHENTERMINE HCL | 37.5 MG | TABLET | ORAL | Y | F | Generic | 1000 | LEADING PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20715 | 10702000109 | LOMAIRA | 8 MG | TABLET | ORAL | N | F | Brand | 90 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20736 | 00002446230 | CIALIS | 5 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | ELI LILLY & CO. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 00002446234 | CIALIS | 5 MG | TABLET | ORAL | N | F | Multi-Source Brand | 30 | ELI LILLY & CO. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 00002446279 | CIALIS | 5 MG | TABLET | ORAL | N | F | Multi-Source Brand | 15 | ELI LILLY & CO. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 00093301730 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 15 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 00093301756 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 00093301765 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | TEVA USA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 00378697193 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | MYLAN | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 13668056630 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | TORRENT PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 16729037010 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | ACCORD HEALTHCA | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 27241011203 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | AJANTA PHARMA L | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 29300028713 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | UNICHEM PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 29300028782 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | UNICHEM PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 31722064430 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | CAMBER PHARMACE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 35573041030 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | BUREL PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 43598057530 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | DR. REDDY'S LAB | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 47335001083 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | SUN PHARMA GLOB | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 60505468403 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | APOTEX CORP | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 62332017815 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | ALEMBIC PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 62332017830 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | ALEMBIC PHARMAC | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 66993070130 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | PRASCO LABS | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 66993070138 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | PRASCO LABS | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 66993070156 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 15 | PRASCO LABS | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 68180092006 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | LUPIN PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 68382089706 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | ZYDUS PHARMACEU | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 69097037402 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | CIPLA USA, INC. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 69097037405 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 90 | CIPLA USA, INC. | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20736 | 69238134703 | TADALAFIL | 5 MG | TABLET | ORAL | N | F | Generic | 30 | AMNEAL PHARMACE | EBD: IMPOTENCE - ORAL, FEMALES PA REQUIRED | |
| 20771 | 00527147501 | DIETHYLPROPION HCL | 25 MG | TABLET | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20771 | 00591078301 | DIETHYLPROPION HCL | 25 MG | TABLET | ORAL | Y | F | Generic | 100 | ACTAVIS/TEVA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20771 | 10702004401 | DIETHYLPROPION HCL | 25 MG | TABLET | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20771 | 10702004406 | DIETHYLPROPION HCL | 25 MG | TABLET | ORAL | Y | F | Generic | 60 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20780 | 00527147701 | DIETHYLPROPION HCL ER | 75 MG | TABLET, EXTENDED RELEASE | ORAL | Y | F | Generic | 100 | LANNETT CO. INC | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20780 | 00591078201 | DIETHYLPROPION HCL ER | 75 MG | TABLET, EXTENDED RELEASE | ORAL | Y | F | Generic | 100 | ACTAVIS/TEVA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20840 | 00185525401 | PHENDIMETRAZINE TARTRATE ER | 105 MG | CAPSULE, EXTENDED RELEASE | ORAL | Y | F | Generic | 100 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20840 | 00185525410 | PHENDIMETRAZINE TARTRATE ER | 105 MG | CAPSULE, EXTENDED RELEASE | ORAL | Y | F | Generic | 1000 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20840 | 69543040910 | PHENDIMETRAZINE TARTRATE ER | 105 MG | CAPSULE, EXTENDED RELEASE | ORAL | Y | F | Generic | 100 | VIRTUS PHARMACE | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 00185405701 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 100 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 00185405710 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 1000 | SANDOZ | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702004501 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702004503 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 30 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702004510 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702007701 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702007703 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 30 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702007710 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702007801 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 100 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702007803 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 30 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 10702007810 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 1000 | KVK-TECH, INC. | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 68462056101 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 100 | GLENMARK PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 68462056110 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 1000 | GLENMARK PHARMA | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 69543041010 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 100 | VIRTUS PHARMACE | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 20852 | 69543041011 | PHENDIMETRAZINE TARTRATE | 35 MG | TABLET | ORAL | Y | F | Generic | 1000 | VIRTUS PHARMACE | TPA - LEGEND ANTI-OBESITY DRUGS REQUIRES PRIOR AUTHORIZATION | |
| 21368 | 44087111501 | GONAL-F RFF REDI-JECT | 300/0.5ML | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 0.5 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 21375 | 44087111601 | GONAL-F RFF REDI-JECT | 450/0.75ML | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 0.75 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 21376 | 44087111701 | GONAL-F RFF REDI-JECT | 900/1.5 ML | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 1.5 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 21450 | 00013265402 | GENOTROPIN | 1.2MG/0.25 | SYRINGE (EA) | SUBCUTANEOUS | N | F | Brand | 7 | PHARMACI/PFIZER | PA DRUGS, DOD PA REQUIRED | |
| 21451 | 00013265502 | GENOTROPIN | 1.4MG/0.25 | SYRINGE (EA) | SUBCUTANEOUS | N | F | Brand | 7 | PHARMACI/PFIZER | PA DRUGS, DOD PA REQUIRED | |
| 21452 | 00013265602 | GENOTROPIN | 1.6MG/0.25 | SYRINGE (EA) | SUBCUTANEOUS | N | F | Brand | 7 | PHARMACI/PFIZER | PA DRUGS, DOD PA REQUIRED | |
| 21453 | 00013265702 | GENOTROPIN | 1.8MG/0.25 | SYRINGE (EA) | SUBCUTANEOUS | N | F | Brand | 7 | PHARMACI/PFIZER | PA DRUGS, DOD PA REQUIRED | |
| 21454 | 00013265802 | GENOTROPIN | 2MG/0.25ML | SYRINGE (EA) | SUBCUTANEOUS | N | F | Brand | 7 | PHARMACI/PFIZER | PA DRUGS, DOD PA REQUIRED | |
| 21573 | 13811053530 | FOLIVANE-OB | 85 MG-1 MG | CAPSULE | ORAL | N | F | Generic | 30 | TRIGEN LABORATO | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21573 | 52747062030 | CONCEPT OB | 85 MG-1 MG | CAPSULE | ORAL | N | F | Multi-Source Brand | 30 | US PHARMACEUTIC | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21574 | 13811053630 | TARON-C DHA | 35-1-200MG | CAPSULE | ORAL | N | F | Generic | 30 | TRIGEN LABORATO | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21574 | 52747062130 | CONCEPT DHA | 35-1-200MG | CAPSULE | ORAL | N | F | Multi-Source Brand | 30 | US PHARMACEUTIC | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21574 | 58657012130 | DOTHELLE DHA | 35-1-200MG | CAPSULE | ORAL | N | F | Generic | 30 | METHOD PHARMAC | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21574 | 76439033130 | VIRT-C DHA | 35-1-200MG | CAPSULE | ORAL | N | F | Generic | 30 | VIRTUS PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21585 | 00813020201 | O-CAL PRENATAL | 15 MG-1 MG | TABLET | ORAL | N | F | Brand | 100 | PHARMICS | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21597 | 66215030300 | VENTAVIS | 20 MCG/ML | AMPUL FOR NEBULIZATION (ML) | INHALATION | Y | F | Brand | 1 | ACTELION PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 21597 | 66215030330 | VENTAVIS | 20 MCG/ML | AMPUL FOR NEBULIZATION (ML) | INHALATION | Y | F | Brand | 1 | ACTELION PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 21728 | 51991017801 | VINATE II | 29 MG-1 MG | TABLET | ORAL | N | F | Generic | 100 | BRECKENRIDGE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 21831 | 00378600191 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | MYLAN | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 00591272060 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | ACTAVIS/TEVA | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 29033003206 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | NOSTRUM LABORAT | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 42806040660 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | EPIC PHARMA LLC | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 50742063460 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | INGENUS PHARMAC | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 59630057560 | FORTAMET | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Multi-Source Brand | 60 | SHIONOGI PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 68084081932 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 20 | AHP | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 68084081933 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 1 | AHP | PA DRUGS, DOD PA REQUIRED | |
| 21831 | 68180033707 | METFORMIN HCL ER | 1000 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | LUPIN PHARMACEU | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 00378600291 | METFORMIN HCL ER | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | MYLAN | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 00591271960 | METFORMIN HCL ER | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | ACTAVIS/TEVA | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 29033003106 | METFORMIN HCL ER | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | NOSTRUM LABORAT | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 42806040560 | METFORMIN HCL ER | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | EPIC PHARMA LLC | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 50742063360 | METFORMIN HCL ER | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | INGENUS PHARMAC | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 59630057460 | FORTAMET | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Multi-Source Brand | 60 | SHIONOGI PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 21832 | 68180033607 | METFORMIN HCL ER | 500 MG | TABLET, EXTENDED RELEASE 24 HR | ORAL | N | F | Generic | 60 | LUPIN PHARMACEU | PA DRUGS, DOD PA REQUIRED | |
| 22645 | 24987011114 | NILANDRON | 150 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 30 | COVIS/CONCORDIA | PA DRUGS, DOD PA REQUIRED | |
| 22645 | 59212011114 | NILANDRON | 150 MG | TABLET | ORAL | Y | F | Multi-Source Brand | 30 | CONCORDIA PHARM | PA DRUGS, DOD PA REQUIRED | |
| 22645 | 62559017331 | NILUTAMIDE | 150 MG | TABLET | ORAL | Y | F | Generic | 30 | ANI PHARMACEUTI | PA DRUGS, DOD PA REQUIRED | |
| 22836 | 00169643810 | LEVEMIR FLEXTOUCH | 100/ML (3) | INSULIN PEN (ML) | SUBCUTANEOUS | N | I | Brand | 3 | NOVO NORDISK | PA DRUGS, DOD PA REQUIRED | |
| 22935 | 42192010515 | BPO | 4 % | GEL (GRAM) | TOPICAL | Y | F | Generic | 42.5 | ACELLA PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 22936 | 42192010615 | BPO | 8 % | GEL (GRAM) | TOPICAL | Y | F | Generic | 42.5 | ACELLA PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00051848888 | ANDROGEL | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | N | F | Multi-Source Brand | 75 | ABBVIE US LLC | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00245087240 | VOGELXO | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Brand | 75 | UPSHER-SMITH LA | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00245087242 | VOGELXO | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Brand | 75 | UPSHER-SMITH LA | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00591292102 | TESTOSTERONE | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Generic | 75 | ACTAVIS/TEVA | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00591292118 | TESTOSTERONE | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Generic | 75 | ACTAVIS/TEVA | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00832112140 | TESTOSTERONE | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Brand | 75 | UPSHER-SMITH LA | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 00832112142 | TESTOSTERONE | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Brand | 75 | UPSHER-SMITH LA | PA DRUGS, DOD PA REQUIRED | |
| 23141 | 45802011602 | TESTOSTERONE | 12.5/1.25G | GEL IN METERED-DOSE PUMP | TRANSDERMAL | Y | F | Generic | 75 | PERRIGO CO. | PA DRUGS, DOD PA REQUIRED | |
| 23495 | 13811058030 | ZATEAN-PN DHA | 27-1-300MG | CAPSULE | ORAL | N | F | Generic | 30 | TRIGEN LABORATO | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 23495 | 42192032130 | PNV-DHA | 27-1-300MG | CAPSULE | ORAL | N | F | Generic | 30 | ACELLA PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 23495 | 58657012230 | RULAVITE DHA | 27-1-300MG | CAPSULE | ORAL | N | F | Generic | 30 | METHOD PHARMAC | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 23495 | 69543034030 | VIRT-PN DHA | 27-1-300MG | CAPSULE | ORAL | N | F | Generic | 30 | VIRTUS PHARMACE | EBD: LEG PRENATAL VIT, AGE >45 PA REQUIRED | |
| 23695 | 44087001601 | SAIZENPREP | 8.8MG/1.51 | CARTRIDGE (EA) | SUBCUTANEOUS | N | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 23695 | 44087108001 | SAIZEN | 8.8MG/1.51 | CARTRIDGE (EA) | SUBCUTANEOUS | N | F | Brand | 1 | EMD SERONO, INC | PA DRUGS, DOD PA REQUIRED | |
| 23761 | 42998050101 | EMFLAZA | 6 MG | TABLET | ORAL | Y | F | Brand | 100 | MARATHON/PTC TH | PA DRUGS, DOD PA REQUIRED | |
| 23761 | 52856050101 | EMFLAZA | 6 MG | TABLET | ORAL | Y | F | Brand | 100 | PTC THERAPEUTIC | PA DRUGS, DOD PA REQUIRED | |
| 23762 | 42998050303 | EMFLAZA | 30 MG | TABLET | ORAL | Y | F | Brand | 30 | MARATHON/PTC TH | PA DRUGS, DOD PA REQUIRED | |
| 23762 | 52856050303 | EMFLAZA | 30 MG | TABLET | ORAL | Y | F | Brand | 30 | PTC THERAPEUTIC | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 00093540189 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | TEVA USA | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 00173088408 | LOVAZA | 1 G | CAPSULE | ORAL | Y | F | Multi-Source Brand | 120 | GLAXOSMITHKLINE | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 00254301008 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | PAR PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 16714066001 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | NORTHSTAR RX LL | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 31722093612 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | CAMBER PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 42291065712 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | AVKARE | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 49884001908 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | PAR PHARM. | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 60505317007 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | APOTEX CORP | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 64380076111 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | STRIDES PHARMA | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 65162003416 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | AMNEAL PHARMACE | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 66993072632 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | PRASCO LABS | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 66993083932 | OMEGA-3 ACID ETHYL ESTERS | 1 G | CAPSULE | ORAL | Y | F | Generic | 120 | PRASCO LABS | PA DRUGS, DOD PA REQUIRED | |
| 23929 | 70868015060 | TRIKLO | 1 G | CAPSULE | ORAL | Y | F | Generic | 60 | KEY THERAPEUTIC | PA DRUGS, DOD PA REQUIRED | |
| 24145 | 00169770421 | NORDITROPIN FLEXPRO | 5 MG/1.5ML | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 1.5 | NOVO NORDISK | PA DRUGS, DOD PA REQUIRED | |
| 24146 | 00169770521 | NORDITROPIN FLEXPRO | 10MG/1.5ML | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 1.5 | NOVO NORDISK | PA DRUGS, DOD PA REQUIRED | |
| 24147 | 00169770821 | NORDITROPIN FLEXPRO | 15MG/1.5ML | PEN INJECTOR (ML) | SUBCUTANEOUS | Y | F | Brand | 1.5 | NOVO NORDISK | PA DRUGS, DOD PA REQUIRED | |
| 24203 | 00395808262 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 100 | HUMCO LAB. | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 10695001717 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 500 | WILLOW BIRCH PH | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 37803190803 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 5 | APOTHECA SUPPLY | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 37803190804 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 25 | APOTHECA SUPPLY | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 37803190805 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 100 | APOTHECA SUPPLY | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 37803190807 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 500 | APOTHECA SUPPLY | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 46144032010 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 100 | A.P.I. SOLUTION | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 46144032025 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 25 | A.P.I. SOLUTION | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 58597808802 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 5 | AMERICAN PHARMA | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 58597808803 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 10 | AMERICAN PHARMA | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 58597808804 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 25 | AMERICAN PHARMA | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 58597808805 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 50 | AMERICAN PHARMA | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 58597808806 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 100 | AMERICAN PHARMA | AGE<40, VIAGRA (GC) PA REQUIRED | |
| 24203 | 58597808807 | SILDENAFIL CITRATE | 100 % | POWDER (GRAM) | MISCELLANEOUS | Y | F | Brand | 500 | AMERICAN PHARMA | AGE<40, VIAGRA (GC) PA REQUIRED |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .